Full name
MAYAMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice activities
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade, except of motor vehicles and motorcycles
47 - Retail trade, except motor vehicle retail
72 - Scientific research and development
86 - Human health activities
2022 | 2023 | ||
---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss) | 132,8 | 310,2 | 133,7 |
EBITDA | 134,6 | 332,6 | 147,1 |
Short time liabilities | 87,3 | 16,5 | -81,1 |
Equity capital | 130,8 | 413,1 | 215,8 |
Operating profit (EBIT) | 132,8 | 310,2 | 133,7 |
Assets | 218,1 | 429,7 | 97 |
Net profit (loss) | 120,8 | 282,3 | 133,7 |
Cash | 78,9 | 316,8 | 301,6 |
Net income from sale | 384,9 | 585,5 | 52,1 |
Liabilities and provisions for liabilities | 87,3 | 16,5 | -81,1 |
Working assets | 108 | 341,9 | 216,6 |
Depreciation | 1,9 | 22,4 | 1100 |
% | % | p.p. | |
Profitability of capital | 92,4 | 68,3 | -24,1 |
Equity capital to total assets | 60 | 96,2 | 36,2 |
Gross profit margin | 34,5 | 53 | 18,5 |
EBITDA Margin | 35 | 56,8 | 21,8 |
Days | Days | Days | |
Short term commitment turnover cycle | 83 | 10 | -73 |
Current financial liquidity indicator | 1.2368885278701782 | 20.6734676361084 | 19,5 |
Net dept to EBITDA | -0.06602828949689865 | -0.9525294899940491 | -0,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane